Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prepkit-C
- Development stage
- Phase 4
- Lead developer
- Fresenius Kabi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Prepkit-C is a standard bowel preparation kit used in Australia and New Zealand to cleanse the colon prior to colonoscopy or other gastrointestinal procedures. It is a combination regimen consisting of one sachet of Glycoprep-C (a polyethylene glycol [PEG]-based osmotic laxative containing macrogol 3350, sodium sulfate, sodium chloride, and potassium chloride) and two sachets of Picoprep (containing sodium picosulfate, magnesium carbonate, and citric acid). The kit works by inducing osmotic diarrhea to clear the bowel of fecal matter, ensuring adequate visualization of the colonic mucosa during colonoscopy. Prepkit-C is marketed by Fresenius Kabi and is available over the counter without a prescription.
- Brand names
- Prepkit-CPrepkit C
- Other names
- Prep Kit C
Beyond the preview
Go deeper on Prepkit-C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prepkit-C.